ACADIA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	258	319.59	188.66	114.85	147.44	326.03
Short-Term Investments	589.02	436.4	250.21	301.98	373.27	305.93
Cash & Short-Term Investments	847.02	755.99	438.87	416.82	520.71	631.96
Cash Growth	49.83%	72.26%	5.29%	-19.95%	-17.60%	-9.39%
Accounts Receivable	115.85	98.74	98.27	62.2	64.37	48.25
Other Receivables	23.59	5.96	4.08	0.89	0.98	2.04
Receivables	139.44	104.7	102.35	63.08	65.34	50.28
Inventory	29.1	21.95	35.82	6.64	7.88	9.68
Prepaid Expenses	60.87	55.68	39.09	21.4	23.89	25.69
Total Current Assets	1,076	938.32	616.13	507.94	617.82	717.62
Property, Plant & Equipment	53.38	50.79	56.47	61.59	66.32	56.44
Long-Term Investments	-	-	-	-	3.6	1.3
Other Intangible Assets	111.62	119.78	65.49	-	-	1.11
Other Long-Term Assets	89.35	78.87	10.87	18.28	12.38	6.15
Total Assets	1,331	1,188	748.96	587.81	700.12	782.62
Accounts Payable	21.75	16.19	17.54	12.75	6.88	8.49
Accrued Expenses	323.05	254.44	196.16	103.58	80.89	92.39
Current Portion of Leases	11.78	9.96	9.41	9.31	8.3	5.09
Current Income Taxes Payable	-	12.02	1.56	-	-	-
Other Current Liabilities	-	102.26	29.58	-	-	-
Total Current Liabilities	356.58	394.87	254.25	125.63	96.07	105.97
Long-Term Leases	43.03	42.04	47.8	52.7	56.13	44.46
Other Long-Term Liabilities	13.89	18.06	15.15	9.07	7.03	5.18
Total Liabilities	413.5	454.96	317.2	187.4	159.23	155.61
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	3,003	2,937	2,863	2,771	2,695	2,613
Retained Earnings	-2,087	-2,204	-2,431	-2,370	-2,154	-1,986
Comprehensive Income & Other	0.99	0.29	0.02	-0.98	-0.19	0.04
Shareholders' Equity	917.27	732.79	431.76	400.41	540.89	627.01
Total Liabilities & Equity	1,331	1,188	748.96	587.81	700.12	782.62
Total Debt	54.81	52	57.21	62	64.43	49.55
Net Cash (Debt)	792.21	704	381.66	354.82	456.28	582.41
Net Cash Growth	53.54%	84.46%	7.56%	-22.23%	-21.66%	-15.30%
Net Cash Per Share	4.70	4.23	2.33	2.19	2.84	3.70
Filing Date Shares Outstanding	169.18	166.79	164.77	162.23	161.2	160.05
Total Common Shares Outstanding	169.15	166.71	164.65	162.06	161.01	159.64
Working Capital	719.84	543.45	361.87	382.31	521.76	611.65
Book Value Per Share	5.42	4.40	2.62	2.47	3.36	3.93
Tangible Book Value	805.66	613.01	366.27	400.41	540.89	625.9
Tangible Book Value Per Share	4.76	3.68	2.22	2.47	3.36	3.92
Machinery	-	10.16	10.42	10.42	10.54	9.08
Construction In Progress	-	0.52	-	-	-	-
Leasehold Improvements	-	3.75	3.75	3.7	3.7	4.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.